October 2016 VOL 7, NO 9


Letters from Lillie

Celebrating Evidence-Based Research in Oncology Nurse Navigation

Lillie D. Shockney, RN, BS, MAS, ONN-CG 

Dear Navigators, We are greatly looking forward to the Seventh Annual Conference of the Academy of Oncology Nurse & Patient Navigators (AONN+) in Las Vegas. In this issue of the [ Read More ]

Category I: Patient Education, Seventh Annual AONN+ Conference Abstracts

1. Chemotherapy Education Prior to the First Day of Therapy Improves Patient Knowledge

Shari M. Bates, BSN, RN, OCN, CCM
UW Medicine Valley Medical Center, Cancer Support Services, Renton, WA 

Background: Cancer patients experience high rates of anxiety connected to their diagnosis and treatments.1 Education related to side effect management strategies, treatment day expectations, and the infusion environment decrease fear [ Read More ]

Category I: Patient Education, Seventh Annual AONN+ Conference Abstracts

2. Developing the First Global Breast Cancer Education Campaign: Findings on Patient Knowledge and Effective Communication Design

Corrine Ellsworth Beaumont, PhD
WorldwideBreastCancer.com 

Background: Each year, breast cancer kills more than 500,000 women worldwide (World Health Organization [WHO], 2016). In resource-poor settings, most are diagnosed at an advanced stage, with survival rates ranging [ Read More ]

Category I: Patient Education, Seventh Annual AONN+ Conference Abstracts

3. How Patient and Caregiver Informational and Psychosocial Needs Are Being Met in Practice: Results from a National Melanoma Survey

Claire Saxton, MBA; Marni Amsellem, PhD; Rhea Suarez
Cancer Support Community, Washington, DC 

Objectives: Cancer patients and caregivers often have significant psychosocial and informational needs. Many healthcare providers and navigators make referrals to educational and support resources, but how well are the concerns [ Read More ]

Category I: Patient Education, Seventh Annual AONN+ Conference Abstracts

4. Identifying Gaps in Metastatic Breast Cancer Patient Knowledge and Their Communication Experiences with Healthcare Professionals

Corrine Ellsworth Beaumont, PhD1; Katherine Crawford-Gray, MBA, MSc2
1WorldwideBreastCancer.com; 2Metastatic Breast Cancer Alliance 

Objectives: When patients are told they have metastatic breast cancer (MBC), it’s very difficult for them to absorb and interpret what is being told to them at the time of [ Read More ]

Category I: Patient Education, Seventh Annual AONN+ Conference Abstracts

5. The Role of the Navigator in the Oral Chemotherapy Process: Ensuring Compliance and Patient Safety

Terra Dillard, RN; Alison Hammond, BS; Patricia Hegedus, MBA, BSN, RN, OCN; Lyndsey McGrath, RPh; Christina Sloan, MSN, RN, OCN
Bon Secours St. Francis Health System, Greenville, SC 

Objectives: The management and monitoring of oral chemotherapy is complex. Components include documentation of the oral chemotherapy plan, education, adherence, and monitoring for toxicities. Bon Secours St. Francis Health System’s [ Read More ]

Category I: Patient Education, Seventh Annual AONN+ Conference Abstracts

6. Using the Power of Design to More Effectively Communicate with Metastatic Breast Cancer Patients, the “Dandelion Toolkit”

Corrine Ellsworth Beaumont, PhD1; Katherine Crawford-Gray, MBA, MSc2
1WorldwideBreastCancer.com; 2Metastatic Breast Cancer Alliance 

Background: Metastatic breast cancer (MBC) patients receive an overwhelming amount of information at the time of diagnosis, with most of the information transferred through oral conversations and abstract medical terminology [ Read More ]

Category II: Psychosocial Support, Seventh Annual AONN+ Conference Abstracts

7. Financial Navigation: Justification, Benefits, and Program Management

Matt Sherer, MBA, MHA
FirstHealth of the Carolinas 

Objectives: Define financial toxicity in cancer patients; determine the value of financial navigators (FNs) to patients; evaluate costs/benefits of financial navigation to healthcare organizations; evaluate the utility of toolsets for [ Read More ]

Category II: Psychosocial Support, Seventh Annual AONN+ Conference Abstracts

8. Social Support Is a Moderator in the Relationship Between Comorbidity Medication Adherence and Healthy Days for Patients with Metastatic Cancer

Dana Drzayich Antol, MS1; Adrianne W. Casebeer, PhD, MPP, MS1; Sari Hopson, PhD, MSPH1; Raya Khoury, MPH2; Aparna Parikh, MD2; Alisha Stein, RN-NC, MSN, OCN2; Todd Michael, PharmD, RPh2; Stephen Stemkowski, PhD, MHA1; Mikele Bunce, PhD, MPH2
1Comprehensive Health Insights, Humana Inc, Louisville, KY; 2Genentech Inc, South San Francisco, CA 

Objectives: Research suggests that medication adherence improves quality of life. This study explored the influence of social support (SS) on the relationship between comorbidity medication adherence (CMA) and health-related quality [ Read More ]

Category II: Psychosocial Support, Seventh Annual AONN+ Conference Abstracts

9. Travel Burden and Distress in Veterans with Head and Neck Cancer

Tamarind Keating, ARNP, MPH
VA Puget Sound Health Care System, Seattle, WA 

Background: Rural cancer patients often travel long distances to access specialty care. The time and cost of travel and spending an extended period of time away from home can be [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

10. AONN+ Announces Standardized Navigation Metrics

Authors: Project Team Leaders: Tricia Strusowski, MS, RN, Oncology Solutions; Elaine Sein, RN, BSN, OCN, CBCN, Consultant; Danelle Johnston, RN, MSN, OCN, CBCN, Director of Navigation, Sarah Cannon.
Project Team: Sharon Gentry, RN, MSN, CBCN; Elizabeth Brown, MHA, OCN; Nicole Messier, RN, BSN; Barbara McHale, RN, BS, OCN, CBCN; Cheryl Bellomo, RN, BSN, OCN; Linda Bily, MA, CSA; Vanessa Rodriguez, MSW 

Background: There is a gap in the literature regarding the key areas that measure the success of navigation programs: patient experience (PE), clinical outcomes (CO), and business performance or return [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

11. Can Technology Help Us Find Patients? Identifying Patients for Navigation with the Use of a Software Product

Brook Blackmore; Crystal Duggar, RN, MBA, OCN; Mary Rivera, RN, AOCNS
Sarah Cannon, Nashville, TN 

Background: Nursing navigators spend up to 50% of their time identifying cancer patients. Timeliness to care is important to cancer patients early in their diagnosis. Manual identification of cancer patients [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

12. Can Time to Treatment Be Improved for Lung Cancer Patients by Having Their Case Presented at a Thoracic Multidisciplinary Conference?

Wendy L. Brooks, RN; Dawn M. Deacon, RN, BSN, OCN; Lindsey M. Reed, RN, BSN, OCN
Sarah Cannon Cancer Network – HCA Midwest Health 

Background: A positive impact is seen in the timeliness to treatment for cancer patients presented at a thoracic multidisciplinary conference. “Timeliness of treatment delivery is one of the key performance [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

13. Creating a Scorecard to Monitor Program Growth and Evaluate Navigation Metrics in a Multiple-Market Navigation Program

Lisa Hartman, BSEd, MA, RN; Elizabeth Brown, MSN, MHA, RN, OCN
Sarah Cannon 

Objectives: The creation of a defined navigation model, clear navigation metrics, and proof of navigation return on investment (ROI) are essential for “continued development and success of oncology navigation programs.”1 [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

14. Developing a New Specialty Multidisciplinary Clinic While Orienting as a Novice Nurse Navigator

Jeanne Kenna, RN, OCN; Angela Miller, RN, MEd, OCN; Laura Beaupre, RN, BSN, OCN, CB-BN; Jane Zubia, RN, OCN, CN-BN; Maritza Chicas, RN, BSN, OCN, PCCN; Raizalie Roman, RN, BSN, OCN; Cynthia B. Smith, RN, BSN, MA; Alyssa Pauls, RN, BSN, OCN; Kathleen Sevedge, RN, MA, AOCN
Department of Cancer Support Services, Lehigh Valley Health Network Cancer Institute, Allentown, PA 

Background: As our cancer program evolves with multidisciplinary care, leadership approved adding 2 specialty multidisciplinary clinics (MDCs), hepatobiliary (GI) and skin and soft tissue (SST) to existing breast, thoracic, and [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

15. Development and Implementation of an Evidence-Based Educational Program on Hyperglycemia in Cancer Patients for Registered Nurses

Veronica Sampayo, RN, BSN, Doctor of Nursing Practice Student
University of South Florida 

Objectives: The purpose of this evidence-based project was to increase nurse knowledge and awareness of the consequences of hyperglycemia in cancer patients, thereby increasing their capability to effectively intervene. Additionally, [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

16. Interdisciplinary Care Rounds in a Community Cancer Center: Changing the Paradigm of Supportive Service Involvement in Cancer Care

Tina Redenz, RN, BSN; Patricia D. Hegedus, MBA, BSN, RN, OCN
Bon Secours St. Francis Cancer Center 

Background: Cancer centers have focused on optimizing seamless multidisciplinary care at tumor boards and/or clinics, but little has been published on effective ways to involve supportive services in the management [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

17. Lay Navigation: A Quality Improvement Journey

Sonya Lovett 

Background: Oncology navigation has developed over the past several years into a necessary and critical component of cancer care as exemplified by the data available. As a result, cancer centers [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

18. Navigator Identification of Breast Biopsy Results: A Time Analysis of Biopsy Results and Variance in Turnaround Time

Laurie A. Dressman, RN, BA
Sarah Cannon Cancer Institute, Kansas City 

Objective: To improve the turnaround time of breast cancer biopsy pathology to maximize patient care. This includes: Interval between date biopsy performed and initial result showing type of breast cancer [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

19. Oral Chemotherapy Program: Promoting Adherence Through Process Improvement

Kathryn Hall, BSN, RN-BC, ONS-CCP
Lahey Oncology & Hematology at Parkland Medical Center 

Background: In June 2015, ONS published guidelines and evidence-based recommendations to promote safe practices and improve adherence for oral chemotherapy. Adherence to oral agents for cancer (OACs) is an important [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

20. Overcoming Barriers to Lymphedema Education and Treatment for Breast Cancer Patients in Rural Eastern North Carolina

Debra C. Mascarenhas, RN, BSN, BSBA, CBCN; Allyson H. Daugherty, PT, CLT, CFM; Judy Koutlas, RN, MS, OCN
Vidant Medical Center: 

Background: Approximately 42% of breast cancer survivors develop clinically detectable lymphedema within 5 years of treatment. Lymphedema risk factors include axillary node surgery, radiation therapy, infection, tumor growth, and obesity. [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

21. Patient Experience Project (PEP): Understanding the Patient Experience to Enhance Patient Satisfaction and Care Using the DMAIC Process

Kimberly J. Maynard, BSN, RN, OCN; Ellen J. Curri, MSW; Sarah Washburn, MBA
Norris Cotton Cancer Center, Dartmouth-Hitchcock Medical Center, Lebanon, NH 

Objectives: To evaluate the plethora of available materials and standardize information provided to breast cancer patients along the care continuum, with a goal to improve the patient’s experience from diagnosis [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

22. Professional Quality of Life of Staff Nurses in the Cancer Institute of the Philippine General Hospital

Reiner Lorenzo J. Tamayo; Hannah Kristine L. Mugol; Quennie Mae M. Carabit; Tristine Joane M. Briones; Kristel Ann N. Aliwalas; Amirah Samantha DL. Andres; Jahzeel Mae F. Huyo; Cheska Mafaye R. Tablang
College of Nursing, University of the Philippines Manila, Manila, Philippines 

Introduction and Objective: Provision of care by nurses may be influenced by different factors such as their physical, emotional, and psychosocial status. Filipino oncologic nurses are vulnerable to encounter these [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

23. Program Development in Nurse Navigation Is Key to Demonstrating Improved Patient Outcomes

Kris Blackley, RN, BSN, OCN; Victoria Morris, BA; Derek Raghavan, MD, PhD; Marc Kowalkowski, PhD; Carol Farhangfar, PhD, MBA; John Green, MD; Kevin Plate, MBA
Levine Cancer Institute
A division of Carolinas Healthcare System (CHS)
 

Objective: To develop a nurse navigation (NN) program within an academic, multisite community-based cancer institute and implement standardized NN practices to ensure oncology patients receive consistent, high-quality NN support regardless [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

24. Second Opinion? Have Ten! Do MDMs Make a Difference in the Patients’ Plan of Care?

Amy M. Norton, RN, MSN; Erin L. Terwilliger, RN, BSN
Sarah Cannon Cancer Network – HCA Midwest Health 

Background: According to El Saghir and colleagues,1 “Tumor boards (multidisciplinary meetings – MDMs) can be seen as a form of second opinion conducted by a group that includes case review, [ Read More ]

Category III: Quality, Outcomes, and Performance Improvement, Seventh Annual AONN+ Conference Abstracts

25. Using an Integrated Care Model to Conduct Psychosocial Distress Screening

Jennifer Hancock, PsyD; Carrie Wines, RN
CAMC Cancer Center, Charleston, WV 

Background: CAMC Cancer Center is the largest comprehensive cancer center in West Virginia (WV), serving a rural and Appalachian population. The CARE Team consists of 4 nurse and 2 financial [ Read More ]

Category IV: Original Research on Navigation Programs, Seventh Annual AONN+ Conference Abstracts

26. American Cancer Society (ACS) Patient Navigation Program: Who Are We Serving? What Services Are Provided?

Monica Dean, BS; Lynne S. Padgett, PhD
Health Systems, Cancer Control, American Cancer Society 

Objective: Since its inception in 2005, ACS patient navigators have reached over 500,000 patients at hospital sites across the country. The goal of this program is to reduce barriers to [ Read More ]

Category IV: Original Research on Navigation Programs, Seventh Annual AONN+ Conference Abstracts

27. Do Patient Navigators Improve Cancer Care Utilization Behaviors? A Meta-Analysis

Sobia Ali-Faisal, PhD1; Tracey J. F. Colella, RN, PhD2; Naomi Medina-Jaudes1; Lisa Benz Scott, PhD3
1Stony Brook University, Stony Brook, NY; 2Toronto Rehab/University Health Network; 3Stony Brook University Health Sciences Center, Stony Brook, NY 

Objectives: Patient navigation (PN) interventions are increasingly used in cancer care research and practice with unclear results regarding their effectiveness. Meta-analyses are a powerful tool to determine the effectiveness of [ Read More ]

Category IV: Original Research on Navigation Programs, Seventh Annual AONN+ Conference Abstracts

28. The Breast Imaging Nurse Navigator: Measuring the Impact on Coordinated Care Delivery – Results After the First Year

Sharon Inzetta, RN, MS, CBCN, CN-BN
Summa Health System Akron City Hospital Breast Center, Akron, OH 

Objectives: Access, timeliness, patient satisfaction, and outmigration for breast care delivery were all identified as areas for process improvements in our community hospital breast center. In 2015, a dedicated imaging [ Read More ]

Category V: Original Research on Survivorship Programs, Seventh Annual AONN+ Conference Abstracts

29. A Model for Survivorship Care Plans at a Large Academic Institution

Andrew Joseph Ward, John Lawrence Bell, Lindsey Jerkins
The Cancer Institute at The University of Tennessee Medical Center, Knoxville, TN 

Background: In 2014, the American College of Surgeons Commission on Cancer mandated in Standard 3.3 that survivorship care plans (SCPs) be provided for all patients at the completion of active [ Read More ]

Category V: Original Research on Survivorship Programs, Seventh Annual AONN+ Conference Abstracts

30. Electronically Generating the Treatment Summary (TS) and Survivorship Care Plan (SCP) for Cancer Survivors from a Tumor Registry

Regina Franco, MSN, ANP-C; Matthew F. Hudson, PhD; Mark A. O’Rourke, MD; Julia Yates, RN; Patricia Leighton, MSN Ed OCN; Stephanie Hoopes, RN; Douglas McCormick, MSN, APRN-BC; LeAnn Perkins, MSN, ARNP; Kathleen Brant, CTR
Greenville Health System (GHS), Greenville, SC 

Background: Delivery of a personalized TS/SCP for cancer survivors is a widely endorsed standard of care. Few cancer programs are able to deliver the TS/SCP to more than a small [ Read More ]

Category V: Original Research on Survivorship Programs, Seventh Annual AONN+ Conference Abstracts

31. Implementation and Evaluation of an Expanded Survivorship Program

Sara Parise, RN, BSN, OCN, CN-BN; Eileen Brennan-O’Neill, RN, BA, OCN; Karen Gleason, RN, BSN, OCN
Northwell Health Cancer Institute, Monter Cancer Center, Lake Success, NY 

Background: The Northwell Health Cancer Institute consists of 12 disease site Centers of Excellence, one being the Breast Cancer Center of Excellence. Under this scope, the survivorship program for breast [ Read More ]

Category V: Original Research on Survivorship Programs, Seventh Annual AONN+ Conference Abstracts

32. Implementing a Survivorship Program in a Community Hospital–Based Cancer Center to Meet Standard 2.20 for NAPBC Accreditation

Cheryl Syta, RN, MS, AOCNP; Barbara R. McHale, RN, BS, OCN, CBCN; Jessica Sawicki, RN; Jacqueline Dorn, MSW Intern
St. Mary’s Cancer Treatment Center, SPHP, Troy, New York 

Background: The impetus to create a survivorship program at our community hospital–based cancer center was our desire to attain NAPBC accreditation. NAPBC Standard 2.20: a comprehensive breast cancer survivorship care [ Read More ]

Category V: Original Research on Survivorship Programs, Seventh Annual AONN+ Conference Abstracts

33. Questions for Your Survivorship Appointment: A Tool to Screen for Patient Concerns

Stephanie Merce Boecher, RN, OCN, MSN, BSN, BA1; Julia R. Trosman, PhD, MBA2; Patricia A. Robinson, MD3; Frank J. Penedo, PhD4; Sofia F. Garcia, PhD4; Carol A. Rosenberg, MD5; Rosa Berardi6; Javier Macias, BA7; James Gerhart, PhD8; Sarah L. Oberholz, LCSW9; Shakuntala Shrestha, APN10; Pam Khosla, MD10; Oana C. Danciu, MD11; Rajul Kothari, MD11; William Dale, MD, PhD12; Sheetal Mehta Kircher, MD4; Megan R. Slocum, MMS, PA-C13; Christine B. Weldon, MBA2
1Advocate Health Care; 2The Center for Business Models in Healthcare; 3Loyola University Medical Center; 4Northwestern University; 5NorthShore University HealthSystem; 6The Coleman Foundation; 7Leukemia & Lymphoma Society; 8Rush University Medical Center; 9Mercy Hospital and Medical Center; 10Mount Sinai Hospital; 11University of Illinois at Chicago; 12University of Chicago; 13Cancer Survivorship Institute Robert H. Lurie Comprehensive Cancer Center 

Introduction: Cancer and its treatment can have long-lasting or late-onset effects. A robust survivorship program, founded on distress screening and survivorship care plans as recommended by the Institute of Medicine [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

34. AltaMed Health Services: Breast Cancer Outreach and Screening Program

Marlene Luna, MPH; Arlene Bruins, MS
AltaMed Health Services 

Objective: Women living in Los Angeles and Orange County have low mammography screening history; only 65.6% of women have had a mammogram in the past 2 years or less.1 Research [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

35. Church and Academia Collaborate on an Educational Program to Increase Colorectal Cancer Screening (EPICS) in African Americans

Gina Curry, BSPH1; Robyn Espinosa, BS2; Sheila Mahon, BS2; Juned Mohammed, BDS2; Tierra Amos, BS2; Yashika Watkins, PhD, MPH3; Thomas Britt, MD, MPH3
1Chicago State University (CSU) Staff, 2CSU MPH Student, 3CSU Faculty 

Objectives: Colorectal cancer (CRC) is a preventable cancer, yet it is the third most common and second deadliest in the United States. Screening finds the disease at an early stage [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

36. Finding Lung Cancer in the Dark…Utilizing Technology to Help Us Identify Early-Stage Lung Cancer

Brook Blackmore, FNP-BC; Melissa L. Johnson, MD; Tammy Baxter, MD; Howard A. Burris, MD; David R. Spigel, MD; Sharon Moore, RN; Priscilla Smith, RN
Sarah Cannon 

Background: Lung cancer is the leading cancer killer in both men and women in the United States.1 More than half of people with lung cancer die within 1 year of [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

37. Implementing a Breast Screening Assessment Tool in the Inpatient Setting

Nicole DeLano, MSN, RN; Steven Lane, MD; Melissa DeMayo, MSN, RN, LNC
Signature Healthcare 

Problem Addressed: In a recent discussion review on the number of women being screened at the Women’s Imaging Center, the nurse navigator noticed that there was no screening program for [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

38. Model for a Multidisciplinary Cancer Risk Clinic in a Community Setting

Alice Brafford, RN, MSN, CBCN; Amy Bush, RN, MSN, OCN, APN-BC
Novant Health Presbyterian Medical Center 

Objectives: Genetics and genomics are playing an important role in cancer risk assessment. The Novant Health Cancer Risk Clinic was designed to assist patients and healthcare providers in addressing the [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

39. Pathway of a Positive Breast Biopsy: Reducing Testing to Treatment Times

Linda Byrd, ADN, RN-BC, CGRN
Emory Saint Joseph’s Hospital, Atlanta, GA 

Objective: In a suburban community hospital where turnaround times for hormone receptor reports of positive breast biopsies averaged 8 business days, resulting in delayed initiation of treatment, an interdisciplinary breast [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

40. REAL Cancer Study – Expanding Access with Virtual Tumor Boards Through Remote Expert Assessment

J. Horton, BSN, RN; C. Miller, BSN, RN; R. Sanchez, MD; N. Tanner, MD; N. Pastis, MD; K. Taylor; K. Eways; P. Nietert; G. Silvestri, MD
Medical University of South Carolina (MUSC) Hollings Cancer Center 

Rationale: Multidisciplinary tumor boards (MTBs) are extremely effective in achieving multidisciplinary input for National Comprehensive Cancer Network (NCCN) treatment planning. The American College of Surgeons Commission on Cancer recognizes MTBs [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

41. Standard 3.1 Patient Navigation: Developing a Community Needs Assessment (CNA) Adapted to the Veteran Population

Sonya Curry, MSN, RN, ACNS-BC
The Louis Stokes Cleveland Veterans Affairs Medical Center, Cleveland, OH 

Objectives: 1) To improve understanding and completion of a CNA driven by Standard 3.1 Patient Navigation by the American College of Surgeons Commission on Cancer at the Louis Stokes Cleveland [ Read More ]

Category VI: Community Outreach and Screening Programs, Seventh Annual AONN+ Conference Abstracts

42. The Establishment of a Pancreatic Cancer Familial Risk Assessment Program

Nora J. Barrett, BSN, RN, OCN; Kristi L. Case, MS, CHES, CHW; Kristi M. Griffith, MSN, RN, CHPN; Stacey L. Webb, MPA-HCA, BSN, RN
Baylor Charles A. Sammons Cancer Center at Dallas, TX; Baylor University Medical Center, Dallas, TX 

Background: Pancreatic cancer is predicted to become the second leading cause of cancer-related death in the United States by 2020.1 Due to the lack of effective medical treatments for the [ Read More ]

Category VII: Clinical Research, Seventh Annual AONN+ Conference Abstracts

43. A Novel Approach for 2-Stage Breast Reconstruction: Patient-Controlled Tissue Expansion Using the AeroForm CO2 Tissue Expander System

Jenny Saldaña, BA, Patient Navigator and Breast Cancer Survivor
Columbia Presbyterian Medical Center 

Objectives: The tissue expansion process using standard of care, saline-filled expanders is lengthy, inconvenient, and uncomfortable and may lead women to make the decision to decline breast reconstruction. The efficacy [ Read More ]

Category VII: Clinical Research

44. Decision-Making in Cancer Research

Barbara Biedrzycki, PhD, CRNP, AOCNP
Johns Hopkins 

Background: Cancer clinical research is essential to producing evidence-based clinical care that offers better treatment outcomes. Yet the recruiting and consenting process for cancer clinical trials can be challenging and [ Read More ]

Category VII: Clinical Research, Seventh Annual AONN+ Conference Abstracts

45. Eight Case Studies of Concurrent Pathogenic Mutations Identified in Hereditary Breast and Ovarian Cancer Gene Panel

Lilian Servais, MS, LCGC; Lauren Ryan, MS, LCGC; Jeroen Van den Akker, PhD; Annette Leon, PhD, MS, FACMG
Color Genomics 

Objectives: The availability of next-generation sequencing (NGS) and characterization of multiple genes that can increase cancer risk have caused a shift toward multigene panel testing for hereditary cancer. However, the [ Read More ]

Category VII: Clinical Research, Seventh Annual AONN+ Conference Abstracts

46. Interdisciplinary Management of Chemorefractory NHL Patients Treated with KTE-C19 (Anti-CD19 CAR T Cells) in Phase 1 of the ZUMA-1 Clinical Study

Alix Beaupierre,1 Amy Patterson,1 Nicole Kahle,1 Frederick L. Locke,1 Sattva S. Neelapu,2Nancy L. Bartlett,3 Tanya Siddiqi,4 Julio C. Chavez,5 Chitra M. Hosing,6 Amanda Cashen,3 Lihua E. Budde,4 Lynn Navale,7 Yizhou Jiang,7 Meg Elias,7 Jeff Aycock,7 Jeff Wiezorek,7 William Y. Go7
1Department of Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL; 2Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX; 3Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO; 4Department of Hematology and Hematopoietic Cell Transplantation, City of Hope National Medical Center, Duarte, CA; 5Department of Malignant Hematology, Moffitt Cancer Center, Tampa, FL; 6Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX; 7Kite Pharma, Santa Monica, CA 

Objectives: Patients with chemorefractory non-Hodg­kin lymphoma (NHL) have poor response to standard therapy and short overall survival. The objectives of the phase 1 ZUMA-1 trial were to evaluate the safety [ Read More ]

Category VII: Clinical Research, Seventh Annual AONN+ Conference Abstracts

47. Prevention of Everolimus/Exemestane (EVE/EXE) Stomatitis in Postmenopausal (PM) Women with Hormone Receptor–Positive (HR+) Metastatic Breast Cancer (MBC) Using a Dexamethasone-Based Mouthwash (MW): Results of the SWISH Trial

Lindsay Shelby, RN, OCN1; Hope S. Rugo, MD2; Lasika Seneviratne, MD3; John A. Glaspy, MD4; Julio A. Peguero, MD5; Timothy J. Pluard, MD6; Navneet Dhillon, MD7; Leon C. Hwang, MD8; Chaitali Nangia, MD9; Ingrid A. Mayer, MD10; Timothy F. Meiller, DDS11; Mark S. Chambers, DMD12; Jaqueline Rogerio, MD13; Kristina Wagner, MS13; Robert W. Sweetman, MD13; J. Randy Sabo13; J. Thaddeus Beck, MD1 Columbia Presbyterian Medical Center

1Highlands Oncology Group, Rogers, AR; 2University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA; 3Los Angeles Cancer Network, Los Angeles, CA; 4University of California Los Angeles School of Medicine, Los Angeles, CA; 5Oncology Consultants P.A., Department of Research, Houston, TX; 6St. Luke’s Cancer Institute, Kansas City, MO; 7Cancer Treatment Centers of America, Atlanta, GA; 8Kaiser Permanente Mid-Atlantic States, Gaithersburg, MD; 9UC Irvine Health Chao Family Comprehensive Cancer Center, Orange, CA; 10Vanderbilt-Ingram Comprehensive Cancer Center, Nashville, TN; 11Oncology and Diagnostic Sciences, Dental School and The Marlene and Stewart Greenebaum Comprehensive Cancer Center, University of Maryland Medical Center, Baltimore, MD; 12The University of Texas MD Anderson Cancer Center, Houston, TX; 13Novartis Pharmaceutical Corporation, East Hanover, NJ
 

Objective: Stomatitis is a common adverse event (AE) of mTOR inhibition. In BOLERO-2, all-grade (Gr), Gr ≥2 and 3 stomatitis incidence with EVE/EXE was 67%, 33%, and 8%, respectively. Median [ Read More ]

Category VII: Clinical Research, Seventh Annual AONN+ Conference Abstracts

48. Restoring Quality of Life and Hematologic Function with Ibrutinib in Treatment-Naive Patients with Chronic Lymphocytic Leukemia in the RESONATE-2 Study

Sara Deisinger, RN, BSN1; Edythe Greenberg, NP2; Cathy Zhou, MS3; Lori Styles, MD3; Danelle James, MD3; Jan A. Burger, MD, PhD2; Paul M. Barr, MD1
1Wilmot Cancer Institute, University of Rochester, Rochester, NY; 2The University of Texas MD Anderson Cancer Center, Houston, TX; 3Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA 

Objectives: Disease symptoms and treatment complications can profoundly affect quality of life (QOL) in patients (pts) with chronic lymphocytic leukemia (CLL). Ibrutinib (ibr), a B-cell receptor pathway inhibitor, improved QOL [ Read More ]

Category VII: Clinical Research, Seventh Annual AONN+ Conference Abstracts

49. The Association Between Guideline-Recommended Treatment Initiation, Healthy Days, and Patient-Reported Symptoms in Patients with Non–Small Cell Lung Cancer

Adrianne W. Casebeer, PhD, MPP, MS1; Dana Drzayich Antol, MS1; Yong Li, PhD1; Richard W. DeClue, PhD1; Sari Hopson, PhD, MSPH1; Raya Khoury, MPH2; Aparna Parikh, MD2; Alisha Stein, RN-NC, MSN, OCN2; Todd Michael, PharmD, RPh2; Stephen Stemkowski, PhD, MHA1; Mikele Bunce, PhD, MPH2
1Comprehensive Health Insights, Humana Inc, Louisville, KY; 2Genentech Inc, South San Francisco, CA 

Objectives: Previous studies have suggested that guideline-recommended therapy improves survival and reduces cost among patients with metastatic non–small cell lung cancer (mNSCLC). The purpose of this study was to explore [ Read More ]

One Award Nominees

AONN+ Announces the 2016 Oncology Nurse Excellence Award Nominees: Place Your Vote Today

The Academy of Oncology Nurse & Patient Navigators (AONN+) is pleased to announce the 2016 Oncology Nurse Excellence™ (ONE) Award nominees. Nominees are recommended by their peers for their display [ Read More ]